Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2012 Aug 9.
Published in final edited form as: Mucosal Immunol. 2010 Mar 17;3(3):213–215. doi: 10.1038/mi.2010.11

Plasticity of Treg at infected sites

Elizabeth Wohlfert 1, Yasmine Belkaid 1
PMCID: PMC3415210  NIHMSID: NIHMS394473  PMID: 20237465

Regulatory T cells (Treg) control an array of immune responses both in the context of various polarized settings as well as in distinct microenvironments. This implies that maintenance of peripheral homeostasis relies on the capacity of Treg to appropriately adapt to these defined settings while sustaining a regulatory program in the face of inflammation. Adaptation of Treg is particularly critical in tissues constantly exposed to microbes such as the gut or the skin or in the context of exposure to pathogenic microbes. Recent evidence supports the idea that the capacity of Treg to control defined polarized settings can be associated with the acquisition of specific transcription factors previously associated with effector T cell lineages. In this commentary we will discuss how such adaptation of Treg can play a major role in the control of host microbe interaction.

A role for T-bet in the control of Treg function at Th1 sites

One required feature of tissue regulation relies on the proper accumulation of the regulatory cells to the inflamed tissue. Until recently it was unclear how Treg responded to environmental cues and targeted defined sites. A recent report by Koch et al.1 supports the idea that T-bet expression by Treg may be instrumental in the capacity of Treg to accumulate at Th1 polarized sites. Using various experimental settings and in particular Mycobacterium tuberculosis infection, this group demonstrated that acquisition of T-bet via its capacity to induce CXCR3, favors the homing of Treg to Th1 sites of inflammation. In competitive bone marrow chimeras Tbx1−/− Treg cells were out competed by WT Treg during Th1 inflammation suggesting an additional role for T-bet in their survival/proliferation. The induction of T-bet in Treg was found to be IFN-γ dependent yet did not require expression of IL-12Rβ1. Similarly, during T. gondii infection, T-bet expression correlated with expression of CXCR32. When isolated from the primary site of T. gondii infection, small intestine lamina propria DCs readily induced T-bet expression by Treg due, in part, to their capacity to induce IFN-γ by T cells. As LpDCs gained the capacity to produce IL-12 in this environment, T-bet expression was associated with acquisition of responsiveness to IL-12 via enhanced Stat4 phosphorylation2. Other factors—such as IL-27 highly expressed in LpDCs from infected mice—are also likely to contribute to this imprinting. At the population level, the expression of T-bet did not interfere with the capacity of Treg to suppress proliferation of effector T cells in vitro 1, 2. Thus, the appropriation of T-bet appears to provide a fitness advantage to Treg in the context of Th1 polarized infections. Such control can be associated with an enhanced homing property as well as acquisition of responsiveness to defined growth factors such as IL-12 present in Th1 polarized microenvironments.

Adaptation of Treg to sites constitutively exposed to microbes

At steady state, the gut is home to a large number of lymphocytes that have the capacity to produce cytokines such as IL-17, IFN-γ as well as IL-43, 4. This constitutive production of cytokines is tightly controlled by the flora as germ-free mice show extensive deficiencies in intestinal immune system development and basal cytokine production3, 5. Based on the aforementioned findings one can speculate that in order to control immune responses at mucosal sites Treg may express transcriptional programs analogous to tissue resident effector T cells. Furthermore, such barrier surfaces may require more proficient Treg to maintain homeostasis. In support of this theory, previous studies have identified the requirement of two other transcription factors, IRF46 and Stat37, associated with effector function and responsiveness, to be required for the capacity of Treg to control Th2 and Th17 inflammation, respectively. Zheng et al. first demonstrated that IRF4 expression by Treg was required to control Th2 pathology as mice with IRF4−/− Treg succumb to disease directed at multiple barrier sites including the lungs, stomach and pancreas by 3–4 months of age. Similarly, Chaudry et al. showed that selective deletion of Stat3 in Foxp3+ cells resulted in the development of an uncontrolled and lethal Th17 inflammation in the gut. Examination of the requirements for these transcription factors in polarized infectious settings will provide a more complete understanding of the capacity of Treg to adapt to defined microenvironments.

Excessive adaptation as a potential trigger of immunopathology

Initial studies in T helper differentiation described a unidirectional pathway to effector lineage commitment and cytokine production. However, recent evidence showed that lymphocytes maintain a certain degree of plasticity with respect to their capacity to produce cytokines 8, 9. Cells expressing both Foxp3 and IL-17 can be found in mucosal tissue or in vitro cultures 8, 10, 11. Genome wide mapping of H3K4me3 and H3K27me3 performed in ex vivo Treg revealed markers of both repression and induction at the tbx21 locus. On the other side, Ifnγ locus did not show any sign of induction or repression 9 suggesting that it is poised for transcriptional activation. A previous report demonstrated that regulatory T cells expressing both Foxp3 and T-bet were induced by CD8α+DCs and could protect against airway hyperactivity 12. A role for IFN-γ in mediating Treg function has been reported in a model of graft transplants 13 and recent evidence demonstrates that, in vitro, Treg can acquire expression of this cytokine 9; Following oral infection with T. gondii under conditions associated with high immunopathology and eventual death of the infected host Treg can produce IFN-γ, a cytokine responsible for both effector and pathogenic responses during this infection. When isolated from infected animals, Treg were capable to exert effector functions as evidenced by their capacity to activate macrophages and induce parasite killing2. Such an aberrant fate for Treg appears to be associated with, or arise as a consequence of pathology. Indeed, IFN-γ production by Treg was only detected in situations leading to death of the infected host. This would suggest that in the presence of high levels of inflammatory mediators, T-bet expression may reach a threshold that could lead to Treg destabilization. Notably, in T. gondii infected mice the level of T-bet in Treg was much higher than that observed in Treg during M. tuberculosis infection1, 2. Both M. tuberculosis and T. gondii are strong Th1 inducing infections however under certain conditions, T. gondii triggers a cytokine storm, with very high levels of inflammatory cytokines such as of IL-6, IL-27 and IL-12. This in conjunction with severely decreased levels of IL-2, which was also seen during this infection, may act on Treg to imprint an effector phenotype. Indeed, when isolated from the primary site of infection, Lamina propria DCs from T. gondii infected mice can only induce IFN-γ production by Treg in the presence of high levels of IL-12. This implies that acquisition of IFN-γ by these cells requires an amplification loop provided by enhanced IL-12 production, a response not normally seen in the gut environment2.

Another example of adaptation of Treg to microbes was observed in the context of exposure to fungal products. Treg exposed to DCs that had been incubated with curdlan, a β-glucan, co-express RORγt 14. A similar phenotype had been previously described on Treg residing in the intestinal mucosa 15. The physiological relevance of RORγt expression for Treg function remains to be addressed but the observation that microbial products or exposure to sites exposed to microbes favor this phenotype suggests that, as for T-bet, RORγt may represent a positive adaptation of Treg cells in defined settings.

On the other hand, as observed with pathogenic levels of infection with T. gondii, high doses of curdlan led to the production of IL-17 by Foxp3+RORγt+ Treg that was dependent on IL-23 production by DCs. Similarly, Treg resident in mucosal tissues of both mice and human can produce IL-17 16, 15. The roles of IFN-γ or IL-17-producing Treg remain difficult to assess. However, given their high degree of Treg self-reactivity, it is plausible that if armed with effector cytokines these cells can contribute to tissue damage or lose suppressive capacity. Indeed, a recent report highlighted that Foxp3 instability and acquisition of IFN-γ can favor the development of autoimmune diabetes 17.

Control of Treg conversion by defined environment

In addition to the regulation provided by thymically derived Treg, recent findings support the idea that the GI tract represents a privileged site for the induction of Treg from naïve CD4+ T cells. Previous work demonstrated that in vitro Treg conversion was abolished in the presence of Th1 or Th2 associated effector cytokines 1821. Additionally, IL-6 required for polarization towards Th17 can down-modulate Foxp3 expression. Accordingly, conversion in the highly Th1 response to T. gondii is halted2. Interestingly, converted Treg although reduced in number during this infection, still adapt to the Th1 environment by expressing T-bet2 suggesting that plasticity is not the sole prerogative of naturally occurring Treg cells. Previous reports examining both gut and lung inflammation support the idea that restricted or defective Treg conversion can enhance immunopathology 22, 23. The relative contribution of blockade of Treg conversion to the pathology induced by T. gondii remains difficult to evaluate but is likely to play a role in the overall decrease of Treg during this infection. These findings also raise the possibility that exposure to antigen at a time of acute infection may impair the acquisition of tolerance against innocuous antigens (e.g flora or food antigens) that could, in turn, further contribute to the pathologic process.

As highlighted by the studies discussed, plasticity of Treg during infection may play a positive role in their capacity to target defined sites, control polarized settings and survive in a competitive fashion with the cells they have to regulate. On the other hand, acquisition of additional transcription factors may lead to Treg destabilization with acquisition of effect cytokines and in some cases, loss of Foxp3. Another important point to consider is that in most cases strict polarization of immune responses is a rare event in tissues. How Treg integrate these complexes and in some cases antagonistic signals to adapt appropriately remains to be addressed. A further examination of Treg in tissue infected with microbes that induce different classes of immune responses and various levels of pathology will be a powerful tool to define the factors controlling the fate of Treg cells.

Figure 1.

Figure 1

Features of tissue-resident regulatory T cells (Treg) during homeostasis and infection. The schematic depicts the stable expression of Foxp3 during thymic generation (and potentially de novo generation in the gut). As Treg enter the periphery, especially of tertiary tissues, the level of plasticity of Treg increases during homeostasis and especially infection.

References

  • 1.Koch MA, et al. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nature Immunology. 2009;10:1–7. doi: 10.1038/ni.1731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Oldenhove G, et al. Decrease of Foxp3(+) Treg Cell Number and Acquisition of Effector Cell Phenotype during Lethal Infection. Immunity. 2009 doi: 10.1016/j.immuni.2009.10.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Ivanov II, et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe. 2008;4:337–349. doi: 10.1016/j.chom.2008.09.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Hall JA, et al. Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity. 2008 doi: 10.1016/j.immuni.2008.08.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Macpherson AJ, Harris NL. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol. 2004;4:478–485. doi: 10.1038/nri1373. [DOI] [PubMed] [Google Scholar]
  • 6.Zheng Y, et al. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature. 2009;458:351–356. doi: 10.1038/nature07674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Chaudhry A, et al. CD4+ Regulatory T Cells Control TH17 Responses in a Stat3-Dependent Manner. Science. 2009 doi: 10.1126/science.1172702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Lee YK, et al. Late developmental plasticity in the T helper 17 lineage. Immunity. 2009;30:92–107. doi: 10.1016/j.immuni.2008.11.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Wei G, et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity. 2009;30:155–167. doi: 10.1016/j.immuni.2008.12.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Xu L, Kitani A, Fuss I, Strober W. Cutting edge: regulatory T cells induce CD4+CD25−Foxp3− T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J Immunol. 2007;178:6725–6729. doi: 10.4049/jimmunol.178.11.6725. [DOI] [PubMed] [Google Scholar]
  • 11.Yang XO, et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity. 2008;28:29–39. doi: 10.1016/j.immuni.2007.11.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Stock P, et al. Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity. Nat Immunol. 2004;5:1149–1156. doi: 10.1038/ni1122. [DOI] [PubMed] [Google Scholar]
  • 13.Sawitzki B, et al. IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J Exp Med. 2005;201:1925–1935. doi: 10.1084/jem.20050419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Osorio F, et al. DC activated via dectin-1 convert Treg into IL-17 producers. Eur J Immunol. 2008;38:3274–3281. doi: 10.1002/eji.200838950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Zhou L, et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature. 2008;453:236–240. doi: 10.1038/nature06878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Voo KS, et al. Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc Natl Acad Sci U S A. 2009;106:4793–4798. doi: 10.1073/pnas.0900408106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Zhou X, et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol. 2009 doi: 10.1038/ni.1774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Wei J, et al. Antagonistic nature of T helper 1/2 developmental programs in opposing peripheral induction of Foxp3+ regulatory T cells. Proc Natl Acad Sci U S A. 2007;104:18169–18174. doi: 10.1073/pnas.0703642104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Mantel PY, et al. GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells. PLoS Biol. 2007;5:e329. doi: 10.1371/journal.pbio.0050329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Hadjur S, et al. IL4 blockade of inducible regulatory T cell differentiation: the role of Th2 cells, Gata3 and PU.1. Immunol Lett. 2009;122:37–43. doi: 10.1016/j.imlet.2008.11.001. [DOI] [PubMed] [Google Scholar]
  • 21.Caretto D, Katzman SD, Villarino AV, Gallo E, Abbas AK. Cutting edge: the Th1 response inhibits the generation of peripheral regulatory T cells. J Immunol. 184:30–34. doi: 10.4049/jimmunol.0903412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Izcue A, et al. Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis. Immunity. 2008;28:559–570. doi: 10.1016/j.immuni.2008.02.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Curotto de Lafaille MA, et al. Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation. Immunity. 2008;29:114–126. doi: 10.1016/j.immuni.2008.05.010. [DOI] [PubMed] [Google Scholar]

RESOURCES